Skip to main content
. 2016 Mar 11;17:20. doi: 10.1186/s12881-016-0280-8

Table 1.

Overview on the number of carriers of upd(6)mat, upd(16)mat, TS14 and upd(20)mat patients from the literature and clinical data on our patients with 14q32 epimutation

Congenital ID upd(6)mat SRS TS14 upd(16)mata upd(20)mat Patient with 14q32 hypomethylation
Reference available on request [24] [7] available on request [9]
Number of patients 13 20 44 51 72 15
Cases with chromosomal disturbances 4/9 40/44 3/12
Cases with normal phenotype 1 <10c
Major Clinical and Overlapping Findings
 IUGR (<P10) 53.8 % (7/13) 70 % 82 % 87 % 74 % (53/72) 100 % yes
 PNGR (<P10) 3bcases 65 % 57 % 79 % 1 case 100 % yes
 Asymmetry 1 case 30 % 68 % 4 % no
 Relative macrocephaly 1 case 90 % 70 % 56 % 1 case no
 Relative macrocephaly 1 case 1 case no
 Hypotonia 1 case 45 % (n = 143) [25] 93 % 1 case yes
 Abdominal wall defects 1 case rare 1 case no
 Glycemic disorder hypoglycemia:
24 %
hypoglycemia:
19 %; diabetes type 2 reported in later life
hypoglycemia, diabetes type 2 reported in later life hypoglycemia:
1 case
yes
 Precocious puberty frequent frequent 86 % too young
 Mental retardation global delay:
65 %
global delay:
20 %
39 % 1 case
 Speech delay 50 % 39 % yes
 Motor delay 2 cases 50 % (7/14) 76 % (26/34) yes
 Behaviour 20 % 9 %
 Feeding difficulties 1 case 90 % 84 % 43 % 7 cases yes
 Seizures 1 case 1 case 1 case
 Excessive Sweating 75 % 64 %
 Scoliosis 5 % 9 % 23 % 1 case
 Adipostas reported in later life [26] yes
 Dysmorphic/typical facial gestalt 1 case triangular face 6 cases mild yes
 Dlinodactyly/finger abnormalities 45 % 75 % 5 cases yes
 Ear abnormalities low set posterior low set posterior
 Otitis media 20 % 14 % 17.6 % (9/51)

athe majority of patients was identified prenatally, 13 ended as therapeutic abortions. Data on postnatal development are scarcely available. bamong them a patient with CUL7 mutation – 3 M syndrome; c[23]